Sung Who Park, Hui Kyung Kim, Moosa Hasan Zaidi, Ik Soo Byon, Ji Eun Lee, Quan Dong Nguyen
{"title":"Cystoid macular edema after vitrectomy and after phacovitrectomy for epiretinal membrane","authors":"Sung Who Park, Hui Kyung Kim, Moosa Hasan Zaidi, Ik Soo Byon, Ji Eun Lee, Quan Dong Nguyen","doi":"10.1016/j.jcjo.2023.11.020","DOIUrl":"https://doi.org/10.1016/j.jcjo.2023.11.020","url":null,"abstract":"<h3>Objective</h3><p>To compare the incidence of cystoid macular edema (CME) after vitrectomy and CME after phacovitrectomy in patients requiring epiretinal membrane (ERM) removal.</p><h3>Design</h3><p>A retrospective, comparative, interventional study.</p><h3>Methods</h3><p>Medical records of patients who had undergone vitrectomy or phacovitrectomy for ERM removal by a single surgeon were retrospectively reviewed. Phacovitrectomy was performed in all phakic eyes and vitrectomy was performed in all pseudophakic eyes. Increased macular thickness (IMT) was defined as an increase in macular thickness by more than 10% at the postoperative week 4 visit compared to the measurements at baseline.</p><h3>Results</h3><p>There were 214 and 53 eyes in the Phacovitrectomy group and the Vitrectomy group, respectively. IMT occurred in 15.4% of the Phacovitrectomy group, which was higher than the incidence of 3.8% in the Vitrectomy group (p=0.023).</p><h3>Conclusions</h3><p>IMT, that is suspected to be a type of CME, was not uncommon (15.4%) after phacovitrectomy in phakic eyes but was uncommon (4.8%) after vitrectomy alone in pseudophakic eyes. Irvine-Gass syndrome appears to be triggered by crystalline lens removal itself rather than intraocular surgery or surgical trauma alone.</p>","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"75 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139028632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kenneth T. Eng, Parampal S. Grewal, Avner Hostovsky, Amrit S. Rai, Hatim Batawi, Alaa Alali, Peter J. Kertes, Asaph Rolnitsky
{"title":"Survival and characteristics of retinopathy of prematurity in micro-premature infants","authors":"Kenneth T. Eng, Parampal S. Grewal, Avner Hostovsky, Amrit S. Rai, Hatim Batawi, Alaa Alali, Peter J. Kertes, Asaph Rolnitsky","doi":"10.1016/j.jcjo.2023.11.023","DOIUrl":"https://doi.org/10.1016/j.jcjo.2023.11.023","url":null,"abstract":"<h3>Objective</h3><p>To describe the risk and nature of retinopathy of prematurity (ROP) in micro-premature infants (≤26 weeks’ gestational age [GA]).</p><h3>Methods</h3><p>Retrospective analysis of prospectively collected data from infants born at 22–26 weeks’ GA over a 5-year period.</p><h3>Results</h3><p>A total of 502 infants were identified, of whom 414 survived to discharge (82.5%). The Vermont Oxford Network database documented clinical follow-up data and ROP outcomes for all 414 patients; complete ROP clinical records were available for 294 of the infants who survived (70.8%). Forty infants were born between 22 and 23 weeks’ GA (group A, 13.6%), and 254 were born between 24 and 26 weeks’ GA (group B, 86.4%). Survival for group A infants was worse than that of group B infants (66.2% vs 85.4%; <em>p</em> < 0.01). Survival of group A infants improved during the study period (<em>R</em><sup>2</sup> = 0.625). Overall, 59.9% of infants developed any ROP and 8.5% developed type 1 ROP. Group A infants were more likely to develop ROP (90.0% vs 48.6%; <em>p</em> < 0.01) and type 1 ROP (30.0% vs 5.1%; <em>p</em> < 0.01) than group B infants. Group A infants developed ROP at an earlier age (32 + 6 weeks vs 33 + 3 weeks; <em>p</em> = 0.02) and were more likely to have zone I disease on presentation (65.0% vs 20.5%; <em>p</em> < 0.01), but there was no difference in the corrected gestational age of peak severity of ROP (35 + 2 weeks vs 34 + 5 weeks; <em>p</em> = 0.36).</p><h3>Conclusion</h3><p>The most premature infants, born at 22–23 weeks’ GA, develop ROP at an earlier age, are more likely to present with posterior disease, and have a high risk of disease requiring treatment.</p>","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139028623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Charlotte N. Shields, Chenab K. Khakh, G. B. Caudill, Carol L. Shields
{"title":"Patient perspectives on ocular oncology care at hybrid telehealth satellite offices","authors":"Charlotte N. Shields, Chenab K. Khakh, G. B. Caudill, Carol L. Shields","doi":"10.1016/j.jcjo.2023.11.005","DOIUrl":"https://doi.org/10.1016/j.jcjo.2023.11.005","url":null,"abstract":"","PeriodicalId":501659,"journal":{"name":"Canadian Journal of Ophthalmology","volume":"246 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139015694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}